Structure

InChI Key NCXMLFZGDNKEPB-FFPOYIOWSA-N
Smile C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O
InChI
InChI=1S/C33H47NO13/c1-18-10-8-6-4-3-5-7-9-11-21(45-32-30(39)28(34)29(38)19(2)44-32)15-25-27(31(40)41)22(36)17-33(42,47-25)16-20(35)14-24-23(46-24)12-13-26(37)43-18/h3-9,11-13,18-25,27-30,32,35-36,38-39,42H,10,14-17,34H2,1-2H3,(H,40,41)/b4-3+,7-5+,8-6+,11-9+,13-12+/t18-,19-,20+,21+,22+,23-,24-,25+,27-,28+,29-,30+,32+,33-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C33H47NO13
Molecular Weight 665.73
AlogP 0.12
Hydrogen Bond Acceptor 13.0
Hydrogen Bond Donor 7.0
Number of Rotational Bond 3.0
Polar Surface Area 230.99
Molecular species ZWITTERION
Aromatic Rings 0.0
Heavy Atoms 47.0

Pharmacology

Action Mechanism of Action Reference
SEQUESTERING AGENT Ergosterol sequestering agent PubMed PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
- - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Keratitis 3 D007634 ClinicalTrials
Mycoses 2 D009181 ClinicalTrials

Related Entries

Scaffolds

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Eye disorders
43.53
Product issues
15.29
Infections and infestations
12.94
General disorders and administration site conditions
8.24
Nervous system disorders
8.24
Immune system disorders
4.71
Injury, poisoning and procedural complications
3.53
Musculoskeletal and connective tissue disorders
2.35

Cross References

Resources Reference
CAS NUMBER 7681-93-8
ChEMBL CHEMBL1200656
DrugBank DB00826
DrugCentral 1885
FDA SRS 8O0C852CPO
PubChem 5284447
SureChEMBL SCHEMBL18140
ZINC ZINC000008220909